Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and Hyaluronic Acid for Hearing Preservation
NCT01588925Phase 2Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Nov 2011
- Primary completion
- Feb 2013
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone, hyaluronic acid in sensorineural hearing loss (SNHL), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Nov 2011; status: completed.
02
Drugs
dexamethasonehyaluronic acid
03
Conditions
sensorineural hearing loss (SNHL)
Beyond the preview
Go deeper on NCT01588925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01588925.